Fludarabine, Cyclophosphamide, and Rituximab - High Dose Frontline

Clinical trial NCT00794820 · COMPLETED

Trial details

NCT number: NCT00794820
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia

Start date: 2003-12-01
Primary completion: 2014-12-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.